Fig. 3From: Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cellsA Visible separation was not identified clearly between the two groups from the score plot of principal component analysis (PCA). B Partial least-squares determinant analysis (PLS-DA) showed a complete separation of detected ions in parthenolide treated groups from control groups [R2X (cum) = 0.384, R2Y (cum) = 0.907, Q2 (cum) = 0.44]. C Orthogonal projections to latent structures discriminant analysis (OPLS-DA) showed a complete separation of detected ions in parthenolide treated groups from control groups [R2X (cum) = 0.384, R2Y (cum) = 0.907, Q2 (cum) = 0.509]. D Permutation test of the PLS-DA model [Q2-intercept = -0.7946]. E Permutation test of the OPLS-DA model [Q2-intercept = -0.3653]Back to article page